OR-NIKE
5.2.2020 20:02:11 CET | Business Wire | Press release
Today, NIKE, Inc. (NYSE: NKE), unveiled breakthrough innovation for athletes competing in the Tokyo 2020 Games, including footwear designed to provide runners with a measurable performance benefit for a new era of competition. The NEXT% platform, introduced by barrier-breaking marathoner Eliud Kipchoge, will now expand into new disciplines following its unparalleled success in distance running.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20200205005708/en/
Ahead of the hottest Games on record, Nike also debuted progressive new collections featuring sustainable materials for all athletes. As the growing climate emergency continues to disrupt competition and training, Nike’s sustainable innovations signal the brand’s commitment to helping protect the future of the planet – and, consequently, the future of sport. Highlights include our most sustainably designed medal stand uniform in Team USA history, footwear built predominantly from recycled waste and lifestyle apparel that embraces the goal of a zero-carbon future.
“At Nike, we see sport’s greatest stage as our biggest opportunity to show the world what’s possible,” said NIKE, Inc. President and CEO John Donahoe. “After all, what’s at stake isn’t just records, but the future of sport itself. In Tokyo, we’ll help the world’s best reach new levels of performance with our revolutionary platform, while sharing real solutions for the barriers all athletes face under rapidly changing climate conditions.”
- Team USA Medal Stand Collection [link ] : This summer, Team USA will prove the power of sustainability during medal ceremonies. In Tokyo, U.S. medalists will take the podium in iconic Windrunner jackets reengineered with 100% recycled polyester, pants featuring 100% recycled nylon and recycled-rubber Nike Grind trim and the Nike Air VaporMax 2020, constructed with recycled manufacturing material and precision-knit uppers for minimal waste.
- Nike Air Zoom Alphafly NEXT% [link ] : Call it the ultimate test run: when Eliud Kipchoge broke the two-hour marathon barrier in Vienna this past October, he was wearing a prototype of the Nike Air Zoom Alphafly NEXT%. In Summer 2020, Nike’s newest race-day shoe makes its official debut with two new Nike Air Zoom pods, additional foam, an updated carbon fiber plate and an ultra-breathable upper – all adding up to improved cushioning and running economy.
- Nike Air Zoom BB NXT [link ]: Nike Basketball's new Air Zoom BB NXT is engineered to be as light and responsive as possible. With a new Nike Air Zoom pod system, exposed Nike React foam and a thin plate positioned above the foam, the shoe provides athletes with lightweight strength, optimized impact protection and outstanding energy return.
- Nike SB Skateboarding Kits [link ] : For skateboarding’s debut on this summer’s global stage, Nike SB will introduce kits on the forefront of sustainable design. Athletes representing Team USA, France and Brazil will compete in uniforms designed with 100% recycled polyester, pattern efficiency for minimal waste and bright, bold styling (crafted in collaboration with Dutch artist Parra) to celebrate each nation’s unique sport culture.
- Space Hippie [link ] : In addition to product developed for athletes participating in the Tokyo 2020 Games, Nike will launch this spring an exploratory footwear collection that redefines what’s possible with sustainable product design. Space Hippie is constructed by transforming scrap material from factory floors – what Nike’s design teams have called “space junk” – into a radical expression of circular design. Every detail of the Space Hippie capsule collection, from material choices to methods of make to packaging, was chosen with consideration for its environmental impact, adding up to Nike’s lowest carbon footprint footwear.
NIKE, Inc., based near Beaverton, Oregon, is the world’s leading designer, marketer and distributor of authentic athletic footwear, apparel, equipment and accessories for a wide variety of sports and fitness activities. Converse, a wholly-owned NIKE, Inc. subsidiary brand, designs, markets and distributes athletic lifestyle footwear, apparel and accessories. For more information, NIKE, Inc.’s earnings releases and other financial information are available on the Internet at http://investors.nike.com . Individuals can also visit http://news.nike.com and follow @NIKE.
View source version on businesswire.com: https://www.businesswire.com/news/home/20200205005708/en/
Link:
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Vonage and ServiceNow Expand their Partnership24.3.2026 09:20:00 CET | Press release
Vonage Contact Center with ServiceNow Voice integrates enterprise-grade voice and AI capabilities directly into enterprise workflows, boosting agent productivity and customer engagement Vonage, part of Ericsson (NASDAQ: ERIC), today announced the launch of its native integration with ServiceNow Voice, built on the ServiceNow AI Platform, embedding enterprise-grade voice and real-time AI capabilities directly into ServiceNow Customer Service Management (CSM) and IT Service Management (ITSM) workflows for Vonage Contact Center (VCC) customers. Vonage provides a unified service environment for enterprise customer service and IT support teams, enabling agents to deliver exceptional customer experiences while driving improvements to service performance. The integration of VCC with ServiceNow embeds real-time voice and AI capabilities into enterprise workflows, giving them the tools their agents need to streamline case progression, automate workflows, and reduce manual effort. Through the Vo
Omnes Partners With Apex Group to Tokenise Institutional Bitcoin Mining Structured Note on Base24.3.2026 09:00:00 CET | Press release
Omnes today announced a strategic partnership with Apex Group, a leading global financial services provider with over $3.5 trillion in assets serviced, to tokenise its flagship Omnes Mining Note "OMN". The OMN is an institutional grade structured note backed by Bitcoin hashrate, to be issued and managed on the Base Chain, the Ethereum L2 incubating at Coinbase, leveraging Apex Digital 3.0 for comprehensive tokenisation, administration, and transfer agency services as a fully integrated end to end solution. The OMN provides professional non-US investors with direct economic exposure to new Bitcoin production measured in hashrate, which is the computational power used to validate transactions and produce Bitcoin, without the operational complexities of managing mining infrastructure, hardware, energy, or regulatory hurdles. Issued as a secured debt note in Luxembourg, the tokenised OMN combines traditional financial structuring with blockchain enabled features, including on chain transfe
Curatis: Double-Digit Revenue Growth in 2025 and Major Milestones for Corticorelin Achieved24.3.2026 07:00:00 CET | Press release
Curatis Holding AG (SIX:CURN, “Curatis”) reports business revenues of CHF 10.8m (+57%) for 2025. Curatis AG increased sales in its distribution business organically by 13%, from CHF 9.5m to CHF 10.8m. The net result improved from a loss of CHF 4.3m in 2024 to a loss of CHF 1.4m in 2025. Further key statements In September 2025, our development plan for corticorelin was validated at a meeting with the FDA, enabling Curatis to proceed toward a regulatory submission supporting a pivotal study in patients suffering from peritumoral brain edema (PTBE). In November 2025, Curatis raised CHF 1.2m to progress corticorelin. The cash position as of year end 2025 was comfortable, standing at CHF 1.9m. Recently, Curatis announced a license agreement for corticorelin for Japan with significant milestone payments. Business development and finances In 2025, product sales amounted to CHF 10.3m, while service revenue amounted to CHF 0.5m. On a full year basis, Curatis AG increased revenues in its distri
AAD 2026: Galderma Showcases Latest Evidence Supporting Its Full-Spectrum, Science-Driven Solutions for Diverse Skin Needs24.3.2026 07:00:00 CET | Press release
From its Therapeutic Dermatology portfolio, Galderma will present data on the efficacy and safety of Nemluvio® (nemolizumab) in different patient populations with moderate-to-severe atopic dermatitis, including late-breaking data in pediatric patients, and share four posters on AKLIEF® (trifarotene)1-8 Additional presentations related to Dermatological Skincare will explore how artificial intelligence can identify high-risk factors for sensitive skin and Cetaphil® in different skin types9 Data from Galderma’s Injectable Aesthetics portfolio will also show how its hyaluronic acid injectables, Restylane®, and neuromodulator, RelabotulinumtoxinA*, may address aesthetic needs across the face and décolletage10-14 A total of 22 presentations will reinforce the value of Galderma’s broad and comprehensive portfolio in meeting varied patient needs across Therapeutic Dermatology, Injectable Aesthetics and Dermatological Skincare Galderma (SIX: GALD), the pure-play dermatology category leader, wi
Avanzanite Expands French Operations and Appoints Constance Sabbagh as General Manager24.3.2026 07:00:00 CET | Press release
Avanzanite Bioscience B.V., a rapidly growing commercial-stage European specialty pharmaceutical company focused on rare diseases, today announced its expansion into France, Europe’s second largest economy, and the appointment of Constance Sabbagh as General Manager, France. Following a €32 million Series A investment by MVM Partners announced in November 2025, Avanzanite is scaling its European infrastructure into a single, integrated platform across 32 countries – designed to bring rare disease medicines to patients in every European market. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260323639110/en/ Constance Sabbagh, General Manager, France “France is essential to Avanzanite’s European vision,” said Adam Plich, Co-founder and CEO of Avanzanite. “With its leadership in rare disease policy through its National Rare Disease Plans, care networks and scientific innovation, France is one of the most significant healthcare
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
